当前位置:首页 - 行情中心 - 益丰药房(603939) - 财务分析 - 现金流量表

益丰药房

(603939)

  

流通市值:311.66亿  总市值:311.71亿
流通股本:12.12亿   总股本:12.12亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金12,970,362,874.416,655,595,055.9725,476,899,360.2318,703,468,518.23
  收到其他与经营活动有关的现金292,322,002.0844,426,798.87288,148,116.91148,283,132.52
  经营活动现金流入小计13,262,684,876.496,700,021,854.8425,765,047,477.1418,851,751,650.75
  购买商品、接受劳务支付的现金8,342,308,188.843,662,301,479.4614,557,574,284.2510,309,537,960.41
  支付给职工以及为职工支付的现金2,069,087,898.961,198,067,921.613,939,587,865.713,134,581,574.53
  支付的各项税费720,530,230.58306,906,979.331,327,948,156.211,083,282,952.29
  支付其他与经营活动有关的现金561,092,769.92418,359,782.861,718,670,086.44982,574,785.33
  经营活动现金流出小计11,693,019,088.35,585,636,163.2621,543,780,392.6115,509,977,272.56
  经营活动产生的现金流量净额平衡项目000-0.01
  经营活动产生的现金流量净额1,569,665,788.191,114,385,691.584,221,267,084.533,341,774,378.18
二、投资活动产生的现金流量:
  收回投资收到的现金--7,104,317.53-
  取得投资收益收到的现金12,813,000-17,084,00017,084,000
  处置固定资产、无形资产和其他长期资产收回的现金净额1,130,146.661,026,497.4966,273,150.18614,204.36
  收到的其他与投资活动有关的现金15,323,272,808.136,050,272,846.1816,015,012,371.9212,401,641,806.79
  投资活动现金流入小计15,337,215,954.796,051,299,343.6716,105,473,839.6312,419,340,011.15
  购建固定资产、无形资产和其他长期资产支付的现金63,360,568.8953,604,459.82682,673,370.81319,849,827.25
  取得子公司及其他营业单位支付的现金105,199,954.0864,847,698.15254,664,562.64215,727,858.13
  支付其他与投资活动有关的现金15,384,600,0006,126,500,00018,776,985,007.4815,554,160,000
  投资活动现金流出小计15,553,160,522.976,244,952,157.9719,714,322,940.9316,089,737,685.38
  投资活动产生的现金流量净额-215,944,568.18-193,652,814.3-3,608,849,101.3-3,670,397,674.23
三、筹资活动产生的现金流量:
  吸收投资收到的现金1,753,000-5,938,756.586,431,000
  其中:子公司吸收少数股东投资收到的现金1,753,000-5,938,756.586,431,000
  取得借款收到的现金--30,000,0001,803,932,000
  收到其他与筹资活动有关的现金--1,783,932,000-
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计1,753,000-1,819,870,756.581,810,363,000
  偿还债务支付的现金61,429,093.461,429,093.4175,337,093.470,853,093.4
  分配股利、利润或偿付利息支付的现金494,902,456.924,063,315.98951,468,847.52604,739,986.11
  其中:子公司支付给少数股东的股利、利润4,179,101.783,961,138.92104,925,012.9391,771,002.77
  支付其他与筹资活动有关的现金740,812,474.92375,295,058.231,613,265,067.971,225,433,275.83
  筹资活动现金流出小计1,297,144,025.24440,787,467.612,740,071,008.891,901,026,355.34
  筹资活动产生的现金流量净额-1,295,391,025.24-440,787,467.61-920,200,252.31-90,663,355.34
五、现金及现金等价物净增加额58,330,194.77479,945,409.67-307,782,269.08-419,286,651.39
  加:期初现金及现金等价物余额2,160,797,870.522,160,797,870.522,468,580,139.62,468,580,139.6
  期末现金及现金等价物余额平衡项目0000.01
  期末现金及现金等价物余额2,219,128,065.292,640,743,280.192,160,797,870.522,049,293,488.22
补充资料:
  净利润945,793,936.37-1,652,782,285.86-
  资产减值准备46,492,233.84-102,396,476.85-
  固定资产和投资性房地产折旧119,655,431-239,555,369.91-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧119,655,431-239,555,369.91-
  无形资产摊销17,726,568.46-32,025,308.07-
  长期待摊费用摊销107,007,981.24-264,925,013.28-
  处置固定资产、无形资产和其他长期资产的损失-33,874,543.07--49,938,810.67-
  固定资产报废损失1,036,265.72-3,836,499.95-
  财务费用101,032,831.38-174,148,877.4-
  投资损失-69,308,547.03--108,128,784.49-
  递延所得税4,914,715.32--12,515,021.8-
  其中:递延所得税资产减少6,944,265.85-5,971,649.51-
    递延所得税负债增加-2,029,550.53--18,486,671.31-
  存货的减少292,970,637.87--790,972,542.4-
  经营性应收项目的减少1,051,733,287.64--554,453,059.73-
  经营性应付项目的增加-1,749,881,096.93-1,593,308,427.28-
  其他824,451.76-65,423,461.4-
  现金的期末余额2,219,128,065.29-2,160,797,870.52-
  减:现金的期初余额2,160,797,870.52-2,468,580,139.6-
  现金及现金等价物的净增加额58,330,194.77--307,782,269.08-
公告日期2025-08-292025-04-292025-04-292024-10-31
审计意见(境内)标准无保留意见
TOP↑